Dr Amber Kathleen Harrell Kirby, MD | |
673 Mdg, 5955 Zeamer Ave, Jber, AK 99506-3702 | |
(907) 580-2908 | |
Not Available |
Full Name | Dr Amber Kathleen Harrell Kirby |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 673 Mdg, Jber, Alaska |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1669910972 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 0101265126 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Amber Kathleen Harrell Kirby, MD 673 Mdg, 5955 Zeamer Ave, Jber, AK 99506-3702 Ph: (907) 580-2908 | Dr Amber Kathleen Harrell Kirby, MD 673 Mdg, 5955 Zeamer Ave, Jber, AK 99506-3702 Ph: (907) 580-2908 |
News Archive
Researchers from across the U.S., as part of the Infantile Spasms Working Group (ISWG), established guidelines for the diagnosis and treatment of infantile spasms (IS). The goal of the ISWG is to improve patient outcomes by creating protocols that educate pediatricians on early diagnosis and treatment options. Full details of this study appear online in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy.
CombinatoRx, Incorporated today announced the results of a 12 month knee osteoarthritis (OA) Phase 2 extension trial for Synavive™ (CRx-102) at the American College of Rheumatology (ACR) 2009 Annual Meeting in Philadelphia. The data demonstrated that Synavive-treated subjects maintained efficacy levels throughout the 12 month extension trial.
Trauma and injury remains a devastating problem in the U.S. It is the leading cause of death for those under the age of 45.
Research that provides a new understanding as to why ferrets are similar to humans is set to have major implications for the development of novel drugs and treatment strategies.
CardioTech International, Inc., a developer and manufacturer of advanced medical devices and materials for the treatment of a broad range of disease states, today announced that it has received the necessary Ministry of Health approval to add a 4mm graft for the clinical trial of CardioPass , the Company's proprietary synthetic coronary bypass graft. Until now, the trial was only approved for a 5mm graft.
› Verified 3 days ago
Dr. Dewayne Charles Lazenby, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 5955 Zeamer Ave, 673d Mdg, Jber, AK 99506 Phone: 907-580-2908 | |
Lindsay Huckabee, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 5955 Zeamer Ave, Jber, AK 99506 Phone: 907-580-2908 | |
Dr. Charles Quentin Pace, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 5955 Zeamer Ave., 673d Mdg, Jber, AK 99506 Phone: 907-580-1453 | |
Charles Luckey Dunn, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 673 Mdg, 5955 Zeamer Avenue, Jber, AK 99506 Phone: 907-580-2908 | |
Dr. Anne M Murphy, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 5955 Zeamer Ave, Jber, AK 99506 Phone: 907-580-2908 | |
Mr. Brett James Ostrander, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 5955 Zeamer Ave, Jber, AK 99506 Phone: 907-580-2908 |